Organization
SQY Therapeutics
1 clinical trial
Clinical trial
Phase 1/2a, Monocentric, Open Label Study to Evaluate the Safety, PK and PD of SQY51 in Paediatric and Adult Patients With a Genetically Confirmed Diagnosis of Duchenne Muscular DystrophyStatus: Recruiting, Estimated PCD: 2025-02-01